|Articles|September 27, 2018
ActiGraph Launches New Activity Monitor
Advertisement
ActiGraph has announced the launch of its newest activity monitor, the CentrePoint Insight Watch. This watch hopes to deliver high quality, real-world data, and an enhance patient experiences during clinical drug trials and health research studies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
ACT Brief: AI-Enabled End-to-End Trials, New Phase III Data in HIV, and a First-Line Shift in HER2-Positive Breast Cancer
3
Gilead’s ARTISTRY-2 Trial Shows Bictegravir Lenacapavir Combo Matches Biktarvy in Virologically Suppressed Adults With HIV
4
Improved patient recruitment for a Parkinson’s research study
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
